Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10580733 | 0.86 | USP2 (0.47) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL10738390 | 0.83 | USP2 (0.40) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL10579669 | 0.78 | USP2 (0.40) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL10581453 | 0.78 | USP2 (0.39) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL10580436 | 0.76 | USP2 (0.49) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL5408963 | 0.73 | ALDH1A1 (0.54) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL10581245 | 0.72 | USP2 (0.48) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL10578217 | 0.71 | USP2 (0.50) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL16399040 | 0.71 | ALDH1A1 (0.57) | USP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL62391 | 0.71 | ALDH1A1 (0.57) | USP2ALDH1A1ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160016874-A1 | METHOD OF SYNTHESIS | BCS BUSINESS CONSULTING SERVICES PTE LTD. (SG) | 2016-01-21 | — | — | US | claimed |
| EP-2970071-A1 | METHOD OF SYNTHESIS | Bcs Business Consulting Services Pte Ltd (SG) | 2016-01-20 | — | — | EP | claimed |
| WO-2014140655-A1 | METHOD OF SYNTHESIS | BCS BUSINESS CONSULTING SERVICES PTE LTD. (SG) | 2014-09-18 | — | — | WO | claimed |
| US-8410314-B1 | Method of synthesis | BCS BUSINESS CONSULTING SERVICES PTE LTD. (SG) | 2013-04-02 | — | — | US | claimed |
| EP-3838881-B1 | METHOD OF SYNTHESIZING 6-(5-ETHOXYHEPT-1-YL)BICYCLO[3.3.0]OCTAN-3-ONE | GREY PACIFIC LABS LLC (US) | 2024-02-14 | — | — | EP | disclosed |
| EP-3838881-A1 | METHOD OF SYNTHESIZING 6-(5-ETHOXYHEPT-1-YL)BICYCLO[3.3.0]OCTAN-3-ONE | Grey Pacific Labs, LLC (US) | 2021-06-23 | — | — | EP | disclosed |
| EP-3838881-A1 | METHOD OF SYNTHESIZING 6-(5-ETHOXYHEPT-1-YL)BICYCLO[3.3.0]OCTAN-3-ONE | Grey Pacific Labs, LLC (US) | 2021-06-23 | — | — | EP | disclosed |
| CN-107266303-B | Synthesis method | 灰太平洋实验室有限公司 | 2021-04-13 | — | — | CN | disclosed |
| CN-107266303-B | Synthesis method | 灰太平洋实验室有限公司 | 2021-04-13 | — | — | CN | disclosed |
| EP-2970071-B1 | METHOD OF SYNTHESIZING 6-(5-ETHOXYHEPT-1-YL)BICYCLO[3.3.0]OCTAN-3-ONE | GREY PACIFIC LABS LLC (US) | 2020-11-18 | — | — | EP | disclosed |
| US-20190194107-A1 | METHOD OF SYNTHESIS | GREY PACIFIC LABS LLC (US) | 2019-06-27 | — | — | US | disclosed |
| US-20190194107-A1 | METHOD OF SYNTHESIS | GREY PACIFIC LABS LLC (US) | 2019-06-27 | — | — | US | disclosed |
| WO-2014140655-A1 | METHOD OF SYNTHESIS | BCS BUSINESS CONSULTING SERVICES PTE LTD. (SG) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014140655-A1 | METHOD OF SYNTHESIS | BCS BUSINESS CONSULTING SERVICES PTE LTD. (SG) | 2014-09-18 | — | — | WO | disclosed |
| US-8410314-B1 | Method of synthesis | BCS BUSINESS CONSULTING SERVICES PTE LTD. (SG) | 2013-04-02 | — | — | US | disclosed |
| US-8410314-B1 | Method of synthesis | BCS BUSINESS CONSULTING SERVICES PTE LTD. (SG) | 2013-04-02 | — | — | US | disclosed |
| US-4855322-A | ANTIANDROGENS;SKIN DISORDERS | CBD CORPORATION (US) | 1989-08-08 | — | — | US | disclosed |
| US-4731458-A | Spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] derivatives | CBD CORPORATION (US) | 1988-03-15 | — | — | US | disclosed |
| US-4689349-A | Anti-tumor halo bicyclo alkanones | CBD CORPORATION (US) | 1987-08-25 | — | — | US | disclosed |
| US-4689345-A | ANTIANDROGENS | CBD CORPORATION (US) | 1987-08-25 | — | — | US | disclosed |